title: Astrocytes and Parkinson's disease.
authors.affiliation: VA Medical Center, Palo Alto, CA 94304.
authors.forename: L S
authors.initials: LS
authors.lastname: Forno
authors.forename: L E
authors.initials: LE
authors.lastname: DeLanney
authors.forename: I
authors.initials: I
authors.lastname: Irwin
authors.forename: D
authors.initials: D
authors.lastname: Di Monte
authors.forename: J W
authors.initials: JW
authors.lastname: Langston
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000493:pharmacokinetics; D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000473:pathology*; D001711:Biotransformation; D004298:Dopamine / Q000378:metabolism; D005911:Gliosis / Q000209:etiology / Q000473:pathology*; D006801:Humans; D020267:MPTP Poisoning; D008543:Melanins / Q000378:metabolism; D008854:Microscopy, Electron; D008995:Monoamine Oxidase / Q000378:metabolism; D009410:Nerve Degeneration; D009419:Nerve Tissue Proteins / Q000378:metabolism; D010300:Parkinson Disease / Q000150:complications / Q000473:pathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000150:complications / Q000473:pathology*; D012453:Saimiri; D013378:Substantia Nigra / Q000473:pathology
chemical_list: D008543:Melanins; D009419:Nerve Tissue Proteins; C014121:neuromelanin; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008995:Monoamine Oxidase; D004298:Dopamine